Expression of cyclins D1, D2 and E correlates with proliferation of rat stellate cells in culture

Journal of Hepatology

Volumn 30, Issue 6, 1999, Pages 1057-1064

  Kawada, Norifumi ^a   Ikeda, Kazuo ^a   Seki, Shuichi ^a   Kuroki, Tetsuo ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cell cycle; Cyclin; Cyclin dependent kinase; Proliferation; Stellate cells

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; BROXURIDINE; BUCLADESINE; CELL DNA; CYCLIN D1; CYCLIN D2; CYCLIN E; ISOBUTYLMETHYLXANTHINE; PHOSPHATIDYLINOSITOL 3 KINASE; PLATELET DERIVED GROWTH FACTOR B; PROPIDIUM IODIDE; THYMIDINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; CELL CULTURE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL PROTECTION; DNA SYNTHESIS; ENZYME ACTIVATION; IMMUNOBLOTTING; MALE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STELLATE CELL;

EID: 0033002786     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(99)80260-8     Document Type: Article

References (44)

1. Friedman SL. The cellular basis of hepatic fibrosis. N Engl J Med. 328:1993;1828-1835.
2. Pinzani M. Novel insights into the biology and physiology of the Ito cell. Pharmacol Ther. 66:1995;387-412.
3. Gressner AM. Cytokines and cellular crosstalk involved in the activation of fat-storing cells. J Hepatol. 22:((suppl 2)):1995;28-36.
4. Ramadori G. The stellate cell (Ito-cell, fat-storing cell, lipocyte, perisinusoidal cell) of the liver. New insights into pathophysiology of an intriguing cell. Virchows Arch B Cell Pathol. 61:1991;147-158.
5. Ramadori G, Veit T, Schwogler S, Dienes HP, Knittel T, Rieder H, et al. Expression of the gene of the α-smooth muscle-actin isoform in rat liver and in rat fat-storing (ITO) cells. Virchows Arch B Cell Pathol. 59:1990;349-357.
6. Nakatsukasa H, Nagy P, Evarts RP, Hsia CC, Marsden E, Thorgeirsson SS. Cellular distribution of transforming growth factorbeta 1 and procollagen types I, III, and IV transcripts in carbon tetrachloride-induced rat liver fibrosis. J Clin Invest. 85:1990;1833-1843.
7. Malizia G, Brunt EM, Peters MG, Rizzo A, Broekelmann TJ, McDonald JA. Growth factor and procollagen type I gene expression in human liver disease. Gastroenterology. 108:1995;145-156.
8. Pinzani M, Milani S, Herbst H, DeFranco R, Grappone A, Caligiuri A, et al. Expression of platelet-derived growth factor and its receptors in normal human liver and during active hepatic fibrogenesis. Am J Pathol. 148:1996;785-800.
9. Pinzani M, Milani S, Grappone C, Weber FL Jr, Gentilini P, Abboud HE. Expression of platelet-derived growth factor in a model of acute liver injury. Hepatology. 19:1994;701-707.
10. Wong L, Yamasaki G, Johnson RJ, Friedman SL. Induction of beta-platelet-derived growth factor receptor in rat hepatic lipocytes during culture activation in vivo and in culture. J Clin Invest. 94:1994;1563-1569.
11. Pinzani M, Knauss TC, Pierce GF, Hsieh P, Kenney W, Dubyak GR, et al. Mitogenic signals for platelet-derived growth factor isoforms in liver fat-storing cells. Am J Physiol. 260:1991;C485-C491.
12. Pinzani M, Marra F, Caligiuri A, DeFranco R, Gentilini A, Faillini P, et al. Inhibition by pentoxifylline of extracellular signalregulated kinase activation by platelet-derived growth factor in hepatic stellate cells. Br J Pharmacol. 119:1996;1117-1124.
13. Kawada N, Uoya M, Seki S, Kuroki T, Kobayashi K. Regulation by cAMP of STAT1 activation in hepatic stellate cells. Biochem Biophys Res Commun. 233:1997;464-469.
14. Marra F, Ghosh Choudhury G, Abboud HE. Interferon γ-mediated activation of STAT1a regulates growth factor-induced mitogenesis. J Clin Invest. 98:1996;1117-1124.
15. Rockey DC, Maher JJ, Jarnagin WR, Gabbiani G, Friedman SL. Inhibition of rat lipocyte activation in culture by interferon-γ Hepatology. 16:1992;776-784.
16. Mallat A, Preaux A-M, Blazejewski S, Rosenbaum J, Dhumeaux D, Mavier P. Interferon alfa and gamma inhibit proliferation and collagen synthesis of human Ito cells in culture. Hepatology. 21:1995;1003-1010.
17. Beno DWA, Rapp UR, Davis BH. Prostaglandin E suppression of platelet-derived-growth-factor-induced Ito cell mitogenesis occurs independent of raf perinuclear translocation and nuclear proto-oncogene expression. Biochim Biophys Acta. 1222:1994;292-300.
18. Sato T, Kato R, Tyson CA. Regulation of differentiated phenotype of rat hepatic lipocytes by retinoids in primary culture. Exp Cell Res. 217:1995;72-83.
19. Kawada N, Kuroki T, Kobayashi K, Inoue M, Kaneda K. Inhibition of myofibroblastic transformation of cultured rat hepatic stellate cells by methylxanthines and dibutyryl cAMP. Dig Dis Sci. 41:1996;1022-1029.
20. Windmeier C, Gressner AM. Effect of pentoxifyllin on the fibrogenic functions of cultured rat liver fat-storing cells and myofibroblasts. Biochem Pharmacol. 51:1996;577-584.
21. Houglum K, Lee KS, Chojkier M. Proliferation of hepatic stellate cells is inhibited by phosphorylation of CREB on serine 133. J Clin Invest. 99:1997;1322-1328.
22. Nasmyth K. Viewpoint: putting the cell cycle in order. Science. 274:1996;1633-1639.
23. Stillman B. Cell cycle control of DNA replication. Science. 274:1996;1659-1664.
24. Sherr CJ. Cancer cell cycles. Science. 274:1996;1672-1677.
25. Hunter T, Pines J. Cyclins and cancer II: Cyclin D and CDK inhibitors come of age. Cell. 79:1994;573-582.
26. J3/cdk4) for mammalian D type G1 cyclins. Cell. 71:1992;323-334.
27. Matsushime H, Quelle DE, Shurtleff SA, Shibuya M, Sherr CJ, Kato JY. D-type cyclin-dependent kinase activity in mammalian cells. Mol Cell Biol. 14:1994;2066-2076.
28. Matsushime H, Roussel MF, Ashmun RA, Sherr CJ. Colonystimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle. Cell. 65:1991;701-713.
29. Kawada N, Tran-Thi T-A, Klein H, Decker K. The contraction of hepatic stellat (Ito) cells stimulated with vasoactive substances. Possible involvement of endothelin 1 and nitric oxide in the regulation of the sinusoidal tonus. Eur J Biochem. 213:1993;815-823.
30. Kawada N, Seki S, Inoue M, Kuroki T. Effect of antioxidants, resveratrol, quercetin, and N-acetylcysteine, on the functions of cultured rat hepatic stellate cells and Kupffer cells. Hepatology. 27:1998;1265-1274.
31. Jiang W, Kahn SM, Zhou P, Zhang Y, Cacace AM, Infante AS, et al. Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression, and gene expression. Oncogene. 8:1993;3447-3457.
32. Quelle DE, Ashmun RA, Shurtleff SA, Kato J, Bar-Sagi D, Roussel MF, et al. Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts. Genes Dev. 7:1993;1559-1571.
33. Baldin V, Lukas J, Marcote MJ, Pagano M, Draetta G. Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev. 7:1993;812-821.
34. Koff A, Cross F, Fisher A, Schumacher J, Leguellec K, Philippe M, et al. Human cyclin E, a new cyclin that interacts with two members of the cdc2 gene family. Cell. 66:1991;1217-1228.
35. Connell-Crowley L, Elledge SJ, Harper JW. G1 cyclin-dependent kinases are sufficient to initiate DNA synthesis in quiescent human fibroblasts. Curr Biol. 8:1998;65-68.
36. Sadoshima J, Aoki H, Izumo S. Angiotensin II and serum differentially regulate expression of cyclins, activity of cyclin-dependent kinases, and phosphorylation of retinoblastoma gene product in neonatal cardiac myocytes. Circ Res. 80:1997;228-241.
37. Won KA, Xiong Y, Beach D, Gilman MZ. Growth-regulated expression of D-type cyclin genes in human diploid fibroblasts. Proc Natl Acad Sci USA. 89:1992;9910-9914.
38. Surmacz E, Reiss K, Sell C, Baserga R. Cyclin D1 messenger RNA is inducible by platelet-derived growth factor in cultured fibroblasts. Cancer Res. 52:1992;4522-4525.
39. MAPK pathway. J Biol Chem. 271:1996;20608-20616.
40. Cook SJ, McCormick F. Inhibition by cAMP of Ras-dependent activation of Raf. Science. 262:1993;1069-1072.
41. Mallat A, Preaux AM, Serradeil Le Gal C, Raufaste D, Gallois C, et al. Growth inhibitory properties of endothelin-1 in activated human hepatic stellate cells: a cyclic adenosine monophosphate-mediated pathway. Inhibition of both extracellular signal-regulated kinase and c-Jun kinase and upregulation of endothelin B receptor. J Clin Invest. 98:1996;2771-2778.
42. Kato JY, Matsuoka M, Polyak K, Massague J, Sherr CJ. Cyclic AMP-induced G1 phase arrest mediated by an inhibitor (p27Kip1) of cyclin-dependent kinase 4 activation. Cell. 79:1994;487-496.
43. Marra F, Gentilini A, Pinzani M, Choudhury GG, Parola M, Herbst H, et al. Phosphatidylinositol 3-kinase is required for platelet-derived growth factor's actions on hepatic stellate cells. Gastroenterology. 112:1997;1297-1306.
44. Brennan P, Babbage JW, Burgering BM, Groner B, Reif K, Cantrell DA. Phosphatidylinositol 3-kinase couples the interleukin-2 receptor to the cell cycle regulator E2F. Immunity. 7:1997;679-689.